N.B.Medical Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3.22M
- Investors
-
14
N.B.Medical General Information
Description
Developer of neurovascular medical devices and in silico regulatory technologies designed to enable precise, efficient, and accelerated medical device development. The company integrates real world medical device R&D with a regulation integrated computational modeling and simulation (CMS) platform and AI driven digital twin technologies, embedding CMS into each stage of the development process and linking AI enabled regulatory documentation with physical device development and testing, enabling medical device manufacturers to streamline regulatory workflows, improve development accuracy and bring innovative neurovascular devices to market more efficiently.
Contact Information
Website
www.nbmed-inc.comCorporate Office
- MFPR Nihonbashi Honcho Building 9th Floor
- 3-7-2 Nihonbashi Honcho, Chuo-ku
- Tokyo, 103-0023
- Japan
Corporate Office
- MFPR Nihonbashi Honcho Building 9th Floor
- 3-7-2 Nihonbashi Honcho, Chuo-ku
- Tokyo, 103-0023
- Japan
N.B.Medical Timeline
N.B.Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 05-Mar-2026 | $3.22M | Completed | Generating Revenue | ||
| 2. Later Stage VC (Series B) | 05-Mar-2026 | Completed | Generating Revenue | |||
| 1. Seed Round | 17-Dec-2021 | $7.83M | $7.83M | Completed | Startup |
N.B.Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| B Shares | ||||||||
| A1 Shares | ||||||||
| A Shares | 25 | $2575.4 | $2575.4 | 1x | $2575.4 | 0.36% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
N.B.Medical Patents
N.B.Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022239748-A1 | Catheter system and method for operating catheter system | Inactive | 12-May-2021 | ||
| JP-2022133795-A | Catheter | Pending | 02-Mar-2021 | ||
| WO-2022185552-A1 | Catheter | Inactive | 02-Mar-2021 | ||
| EP-3412980-A1 | Air cleaning apparatus with a moist filter | Inactive | 29-May-2017 | ||
| JP-2018200164-A | Fume filter type air cleaner | Active | 29-May-2017 | F24F8/133 |
N.B.Medical Signals
N.B.Medical Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AIST Solutions | Corporation | Minority | ||
| ANRI | Venture Capital | Minority | ||
| Medipal Innovation | Corporate Venture Capital | Minority | ||
| Mitsubishi UFJ Capital | Venture Capital | Minority | ||
| Mizuho Capital | Venture Capital | Minority |
N.B.Medical FAQs
-
When was N.B.Medical founded?
N.B.Medical was founded in 2021.
-
Where is N.B.Medical headquartered?
N.B.Medical is headquartered in Tokyo, Japan.
-
What is the size of N.B.Medical?
N.B.Medical has 10 total employees.
-
What industry is N.B.Medical in?
N.B.Medical’s primary industry is Surgical Devices.
-
Is N.B.Medical a private or public company?
N.B.Medical is a Private company.
-
What is N.B.Medical’s current revenue?
The current revenue for N.B.Medical is .
-
How much funding has N.B.Medical raised over time?
N.B.Medical has raised $26.2M.
-
Who are N.B.Medical’s investors?
AIST Solutions, ANRI, Medipal Innovation, Mitsubishi UFJ Capital, and Mizuho Capital are 5 of 14 investors who have invested in N.B.Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process